CY1115455T1 - Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας - Google Patents

Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας

Info

Publication number
CY1115455T1
CY1115455T1 CY20141100171T CY141100171T CY1115455T1 CY 1115455 T1 CY1115455 T1 CY 1115455T1 CY 20141100171 T CY20141100171 T CY 20141100171T CY 141100171 T CY141100171 T CY 141100171T CY 1115455 T1 CY1115455 T1 CY 1115455T1
Authority
CY
Cyprus
Prior art keywords
dimethylamino
treatment
compounds
fenylo
propanium
Prior art date
Application number
CY20141100171T
Other languages
English (en)
Inventor
Thomas Christoph
Babette-Yvonne Kögel
Elmar Friderichs
Muriel Dr Meen
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1115455(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1115455T1 publication Critical patent/CY1115455T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση αφορά στην χρησιμοποίηση ενώσεων 1-φαινυλο-3-διμεθυλαμινο-προπανίου για την παρασκευή φαρμάκων για την θεραπεία, νευροπαθητικού, κατά προτίμηση πολυνευροπαθητικού, ακόμη κατά προτίμηση διαβητικού νευροπαθητικού πόνου, κατά προτίμηση διαβητικού περιφερικού νευροπαθητικού πόνου, ακόμη κατά προτίμηση για τη θεραπεία διαβητικής περιφερικής νευροπάθειας.
CY20141100171T 2007-03-12 2014-02-28 Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας CY1115455T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007012165A DE102007012165A1 (de) 2007-03-12 2007-03-12 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP08716394.5A EP2117525B1 (de) 2007-03-12 2008-03-10 Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes

Publications (1)

Publication Number Publication Date
CY1115455T1 true CY1115455T1 (el) 2017-01-04

Family

ID=39345501

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100171T CY1115455T1 (el) 2007-03-12 2014-02-28 Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας

Country Status (13)

Country Link
US (2) US20080269326A1 (el)
EP (1) EP2117525B1 (el)
JP (5) JP2010520907A (el)
CA (1) CA2680771C (el)
CY (1) CY1115455T1 (el)
DE (1) DE102007012165A1 (el)
DK (1) DK2117525T3 (el)
ES (1) ES2452830T3 (el)
HR (1) HRP20140280T1 (el)
PL (1) PL2117525T3 (el)
PT (1) PT2117525E (el)
SI (1) SI2117525T1 (el)
WO (1) WO2008110323A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081931A1 (es) 2010-06-15 2012-10-31 Gruenenthal Gmbh Combinacion farmaceutica
WO2012010316A1 (en) * 2010-07-23 2012-01-26 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
WO2012051246A1 (en) 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
PT2680834T (pt) 2011-03-04 2018-01-25 Gruenenthal Gmbh Composição farmacêutica aquosa semissólida contendo tapentadol
DK2680833T3 (en) * 2011-03-04 2016-05-23 Gruenenthal Gmbh PARENTERAL SUBMISSION OF TAPENTADOL
SI2680832T1 (sl) 2011-03-04 2019-11-29 Gruenenthal Gmbh Vodna farmacevtska formulacija tapentadola za peroralno dovajanje
PT2694050T (pt) * 2011-04-05 2019-11-22 Gruenenthal Gmbh Tapentadol para uso no tratamento da dor associada à neuralgia trigeminal
WO2012136349A1 (en) 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol for preventing chronification of pain
RS60152B1 (sr) 2011-04-29 2020-05-29 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
EP2617706B1 (en) 2011-07-29 2017-09-06 Anhui New Star Pharmaceutical Development Co., Ltd Novel intermediate used for preparing tapentadol or analogues thereof
SI2736501T1 (en) * 2011-07-29 2018-03-30 Gruenenthal Gmbh Intrathecal or epidural administration of 3 - ((1S, 2S) -3- (dimethylamino) -1-ethyl-2-methylpropyl) phenol
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
CN107847471A (zh) 2015-03-27 2018-03-27 格吕伦塔尔有限公司 他喷他多肠胃外给药的稳定制剂
EP3515412A1 (en) 2016-09-23 2019-07-31 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
EP3585370A1 (en) 2017-02-23 2020-01-01 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
SI1685829T1 (sl) * 2002-11-22 2008-08-31 Gruenenthal Gmbh Uporaba (1RS,3RS,6RS)-6-dimetilaminometil-1- (3-metoksi-fenil)-cikloheksan-1, 3-diola za zdravljenje vnetne bolečine
BRPI0710682B8 (pt) * 2006-04-28 2021-05-25 Gruenenthal Gmbh combinação farmacêutica compreendendo 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol e paracetamol

Also Published As

Publication number Publication date
EP2117525A1 (de) 2009-11-18
PT2117525E (pt) 2014-02-14
SI2117525T1 (sl) 2014-03-31
ES2452830T3 (es) 2014-04-02
CA2680771A1 (en) 2008-09-18
JP6745959B2 (ja) 2020-08-26
JP2013256540A (ja) 2013-12-26
DE102007012165A1 (de) 2008-09-18
PL2117525T3 (pl) 2014-05-30
EP2117525B1 (de) 2013-12-25
JP2016056188A (ja) 2016-04-21
CA2680771C (en) 2015-11-17
JP2018030886A (ja) 2018-03-01
JP2019196405A (ja) 2019-11-14
DK2117525T3 (da) 2014-02-03
US8536130B2 (en) 2013-09-17
US20080269326A1 (en) 2008-10-30
JP6081337B2 (ja) 2017-02-15
HRP20140280T1 (hr) 2014-04-25
US20100311842A1 (en) 2010-12-09
JP2010520907A (ja) 2010-06-17
WO2008110323A1 (de) 2008-09-18

Similar Documents

Publication Publication Date Title
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
ATE534378T1 (de) Titrierung von tapentadol
MA32562B1 (fr) Composes organiques pour la cicatrisation de lesion
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1112067T1 (el) Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας
CY1113024T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων
CY1115254T1 (el) Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
CY1122416T1 (el) Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
EA201170521A1 (ru) Новые соединения
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
EA201000105A1 (ru) Химические соединения
EA201001639A1 (ru) Композиции и способы их получения и применения
EA201071144A1 (ru) Гетероциклические производные
IN2012DN01435A (el)
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
EA201100255A1 (ru) 5-алкинилпиримидины
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
UA107183C2 (uk) Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
CY1116840T1 (el) Χρηση 24-norudca